US Patent 9616049 Dexmedetomidine premix formulation
Patent 9616049 was granted and assigned to Hospira on April, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9616049 Dexmedetomidine premix formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
